CPAC NYSE Week ended 31 Jul 2026

Weekly Investor Report

Cementos Pacasmayo SAA ADR · Basic Materials · Building Materials

Open interactive chart View report data
Latest close 11.80 USD
-1.3% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 8.5% above the Trend Line and sits at 87.5% of its 52-week range. The latest completed week returned -1.3%, after a -1.0% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 56/100. Near-term considerations: earnings are due in 88d.

Setup score 68 out of 100
Latest Close 11.80 USD 31 Jul 2026
1W Return -1.3% latest completed week
4W Return -1.0% short-term follow-through
12W Return 10.8% quarterly tape
Trend Breadth 100.0% 52 of 52 weeks active
Volume Ratio 1.5x vs 13-week average
What is working
  • The trend backdrop is active with a 58-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.3% Latest completed week; four-week move -1.0%. Indicator stack 100/53 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 56/100 49 relevant articles in the latest sentiment read. Event risk 88d Next report is scheduled for 28 Oct 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 8.5% above the Trend Line and sits at 87.5% of its 52-week range. The latest completed week returned -1.3%, after a -1.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8912-week average 0.79

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.89Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -1.0% over four weeks, 10.8% over 12 weeks, and 102.6% over one year. The current trend has remained active for 58 consecutive weeks.

Performance by holding period

1W-1.3%
4W-1.0%
12W10.8%
26W7.2%
52W102.6%
Active trend streak58 weeks
Active weeks in one year52
Trend breadth100.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.32Latest activity-pressure read.
Pressure change-30.6%Four-week change in activity pressure.
Leadership18.36Latest relative-leadership reading.
RS change-25.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Jun 2026 Field coverage 100% Model confidence 100%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength100/100Blend of value, momentum, and quality. Underlying universe rank 1; rank 1 is best.
Value98/100Relative valuation strength. Underlying universe rank 3; rank 1 is best.
Quality88/100Profitability and accounting quality. Underlying universe rank 13; rank 1 is best.
Momentum95/100Medium-term price momentum. Underlying universe rank 6; rank 1 is best.
Growth76/100Revenue and earnings growth. Underlying universe rank 25; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework88/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
4.8x
Price divided by trailing earnings.
Price / sales
0.5x
Market value relative to trailing revenue.
EV / EBITDA
3.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
26.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
40.0%
Gross profit retained from each unit of revenue.
Operating margin
19.8%
Operating profit retained from revenue.
Free-cash-flow margin
26.0%
Free cash flow generated from revenue.
Return on invested capital
10.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
10.9%
Latest one-year revenue growth.
EPS growth
-0.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
29.0%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
17.1%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
17.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment56/100

Weighted news tone is neutral across 49 relevant articles.

14 positive · 33 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings88dNext report is scheduled for 28 Oct 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-7.1%Distance below the 52-week high.
13-week volatility5.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2615 weeks finished lower.
Best week+19.0%Week of 19 Jun.
Worst week-5.4%Week of 13 Mar.
Latest week-1.3%Week of 31 Jul.

Shape of recent returns

Strong gains3
Modest gains6
Flat weeks2
Modest losses11
Sharp losses4
Recent vol5.7%13-week weekly-return volatility.
Base vol8.1%52-week weekly-return volatility.
Up/down split24/25Count of positive and negative weeks in the 52-week window.
Average skew5.6% / -2.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape71/100

Trend, activity pressure, participation, and risk combine to a 71/100 tape read.

 Indicator analysis75/100

Latest 12-week confirmation: trend 12/12, activity pressure 6/12, relative leadership 12/12.

Activity pressure 0.89; 2 reversal markers Factors94/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 63; Small Cap Core rank 2 SVQF88/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 118.5 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment56/100

Weighted news tone is neutral across 49 relevant articles.

CPAC|Cementos Pacasmayo SAA|Price:12.050|Chg%:-0.050 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings88d

Next report is scheduled for 28 Oct 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202611.80 USD-1.3%10.88 USD6.26 USD0.3218.36425.6KOn
24 Jul 202611.95 USD2.1%10.82 USD6.21 USD0.3422.30245.1KOn
17 Jul 202611.70 USD2.5%10.78 USD6.16 USD0.4720.24172.2KOn
10 Jul 202611.42 USD-4.2%10.74 USD6.11 USD0.6616.71376.0KOn
3 Jul 202611.92 USD-0.9%10.59 USD6.07 USD0.4724.6535.7KOn
26 Jun 202612.03 USD-5.3%10.42 USD6.01 USD0.1329.86554.6KOn
19 Jun 202612.70 USD19.0%10.24 USD5.96 USD-0.2835.371.5MOn
12 Jun 202610.67 USD2.6%10.04 USD5.91 USD-0.6616.2155.2KOn
5 Jun 202610.40 USD-1.1%9.91 USD5.86 USD-0.6914.8550.0KOn
29 May 202610.52 USD-2.2%9.78 USD5.82 USD-0.6214.15111.8KOn
22 May 202610.76 USD2.4%9.65 USD5.78 USD-0.6219.2976.7KOn
15 May 202610.51 USD-1.3%9.52 USD5.74 USD-0.5918.5386.6KOn
8 May 202610.65 USD0.0%9.39 USD5.70 USD-0.4521.42101.0KOn
1 May 202610.65 USD-0.5%9.26 USD5.65 USD-0.3525.3467.7KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.